Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Modeling in Therapy01:26

Modeling in Therapy

480
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
480
Gene Therapy00:59

Gene Therapy

27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
What are Viruses?00:50

What are Viruses?

128.3K
Overview
128.3K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.7K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.7K
Group Therapy01:26

Group Therapy

450
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
450

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dynamic PD-L1 Regulation Shapes Tumor Immune Escape and Response to Immunotherapy.

Cancers·2025
Same author

Dynamic PD-L1 Regulation Shapes Tumor Immune Escape and Response to Immunotherapy.

bioRxiv : the preprint server for biology·2025
Same author

Go-or-grow-or-die as a framework for the mathematical modeling of glioblastoma dynamics.

Mathematical biosciences·2025
Same author

Traveling wave speed and profile of a "go or grow" glioblastoma multiforme model.

Communications in nonlinear science & numerical simulation·2022
Same author

Revisiting the growth rate hypothesis: Towards a holistic stoichiometric understanding of growth.

Ecology letters·2022
Same author

High Accuracy Indicators of Androgen Suppression Therapy Failure for Prostate Cancer-A Modeling Study.

Cancers·2022

Related Experiment Video

Updated: Feb 7, 2026

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

9.9K

A Minimal Model Framework for Robust CAR-T Cell and Oncolytic Virus Combination Therapy.

Aisha Tursynkozha1, Yang Kuang2

  • 1School of Artificial Intelligence and Data Science, Astana IT University, Astana, 010000, Kazakhstan.

Research Square
|February 6, 2026
PubMed
Summary

Mathematical models simplify combination immunotherapy for glioblastoma. A quasi-steady-state (QSS) model accurately predicts outcomes using CAR-T cells and oncolytic viruses, aiding treatment optimization.

Keywords:
CAR-T therapyCombination therapyGlioblastomaMathematical modelingOncolytic virusTherapeutic synergy

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

9.5K
Ex Vivo Infection of Live Tissue with Oncolytic Viruses
12:08

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Published on: June 25, 2011

13.3K

Related Experiment Videos

Last Updated: Feb 7, 2026

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

9.9K
Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

9.5K
Ex Vivo Infection of Live Tissue with Oncolytic Viruses
12:08

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Published on: June 25, 2011

13.3K

Area of Science:

  • Oncology
  • Immunotherapy
  • Mathematical Modeling

Background:

  • Glioblastoma is a highly lethal brain cancer.
  • Combination therapy with CAR-T cells and oncolytic viruses shows potential but lacks mechanistic understanding.
  • Synergistic mechanisms in glioblastoma combination immunotherapy require elucidation.

Purpose of the Study:

  • To develop and validate mathematical models for predicting glioblastoma combination immunotherapy outcomes.
  • To analyze the interaction between IL-13Rα2-targeting CAR-T cells and the oncolytic virus C134.
  • To assess the utility of quasi-steady-state (QSS) approximations in simplifying complex immunotherapy models.

Main Methods:

  • Development of a minimal mathematical model framework for glioblastoma immunotherapy.
  • Application of timescale separation and quasi-steady-state (QSS) approximations to reduce model complexity.
  • Comparison of full and QSS models using patient-derived glioblastoma data and Akaike Information Criterion (AIC).

Main Results:

  • The QSS model, with 9 parameters, achieved comparable fits to the full 11-parameter model.
  • QSS models were generally favored by AIC, indicating improved parsimony and predictive power.
  • CAR-T cell exhaustion dynamics did not significantly improve model fits within a 72-hour window.

Conclusions:

  • Simplified QSS formulations effectively capture viral dynamics in combination immunotherapy.
  • The QSS model provides a practical and accurate framework for optimizing glioblastoma combination immunotherapies.
  • Further investigation into CAR-T cell exhaustion may be warranted beyond the initial 72-hour timeframe.